Magenta Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.67
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.27
|
0.03
|
10.00%
|
|
2022-06-30
|
-0.33
|
-0.29
|
0.04
|
12.12%
|
|
2022-03-31
|
-0.31
|
-0.39
|
-0.08
|
-25.81%
|
|
2021-12-31
|
-0.32
|
-0.33
|
-0.01
|
-3.13%
|
|
2021-09-30
|
-0.33
|
-0.30
|
0.03
|
9.09%
|
|
2021-06-30
|
-0.38
|
-0.32
|
0.06
|
15.79%
|
|
2021-03-31
|
-0.40
|
-0.36
|
0.04
|
10.00%
|
|
2020-12-31
|
-0.41
|
-0.38
|
0.03
|
7.32%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.95
|
|
2021-12-31
|
-1.31
|
|
2020-12-31
|
-1.74
|
|
2019-12-31
|
-2.05
|
|
2018-12-31
|
-8.57
|
|
2017-12-31
|
-1.18
|